Blog

Moody's MCO has reported second-quarter 2025 adjusted earnings of $3.56 per share, which outpaced the Zacks Consensus Estimate of $3.44. The bottom line grew 8.5% from the year-ago quarter

For the quarter ended June 2025, First Community (FCCO) reported revenue of $19.53 million, up 19.5% over the same period last year. EPS came in at $0.67, compared to $0.42 in the year-ago quarter.

AT&T Inc. T reported strong second-quarter 2025 results with adjusted earnings and revenues beating the respective Zacks Consensus Estimate.The company witnessed solid wireless traction and customer

Merck’s MRK primary strength lies in oncology, propelled by its blockbuster PD-L1 inhibitor, Keytruda, which fuels robust growth across various cancer indications worldwide. The drug alone accounts

America Movil, S.A.B. de C.V. (AMX) reported net income per ADR of 38 cents for second-quarter 2025 against net loss per ADR of 2 cents reported in the prior-year quarter. The earnings figure,

GameStop Corp. GME has experienced a significant decline over the past three months, with its shares plummeting 10.4%, underperforming the Zacks industry's rally of 28.9%. The company also trailed

East West Bancorp, Inc.’s EWBC second-quarter 2025 adjusted earnings per share (EPS) of $2.28 beat the Zacks Consensus Estimate of $2.23. Moreover, the bottom line increased 9.1% from the prior-year

Essex Property Trust, Inc. ESS is scheduled to report its second-quarter 2025 results on July 29, after market close. The company’s quarterly results are likely to reflect year-over-year growth in

SAP SE (SAP) reported second-quarter 2025 non-IFRS earnings of €1.50 ($1.70) per share, climbing 37% from the year-ago quarter’s levels. The Zacks Consensus Estimate was pegged at $1.63.

Driven by

Applied Digital APLD has taken a significant leap in its hyperscale strategy with a 250MW lease agreement with CoreWeave CRWV for its Ellendale campus. This high-profile win not only validates

Pfizer PFE is due to report second-quarter results on Aug. 5. All eyes will be on sales of Pfizer’s oncology drugs, which account for around 25% of the company’s total revenues. Pfizer’s key

Wednesday, July 23, 2025Pre-market futures are up today, led by foreign auto companies — particularly those in Japan. A new trade agreement was announced that lowers tariffs on Japanese imported

Intuit Inc. INTU unveiled its newest agentic AI enhancements for Intuit Enterprise Suite this week. The update introduces four AI agents — Finance, Payments, Accounting, Project Management — that

Energy Transfer LP ET is expanding its organic asset base to meet increasing pipeline and storage requirements across the United States. With demand increasing for pipeline capacity, natural gas

NVR (NVR) came out with quarterly earnings of $108.54 per share, beating the Zacks Consensus Estimate of $104.89 per share. This compares to earnings of $120.69 per share a year ago. These figures

First Community (FCCO) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.42 per share a year ago. These

China-based NIO Inc. NIO and California-based Lucid Motors LCID are chasing the electric vehicle (EV) opportunity with different approaches. While NIO is expanding into the mass market with a

Thermo Fisher Scientific Inc.'s TMO second-quarter 2025 adjusted earnings per share (EPS) of $5.36 beat the Zacks Consensus Estimate by 2.7%. However, the figure decreased 0.2% year over year.

The

The widely diversified Zacks Transportation sector is currently navigating a challenging macroeconomic environment. The sector grapples with multiple headwinds, ranging from escalated expenses

The Zacks Mortgage & Related Services industry continues to be hindered by volatility in mortgage rates due to macroeconomic uncertainty. With relatively higher mortgage rates, the purchase

Investors in Ryan Specialty Holdings, Inc. RYAN need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 17, 2025 $35.00 Call had some of the

Last week, The Wall Street Journal reported that the Trump administration is likely to issue an executive order that would open the retirement market to private assets.

Shares of the largest private

Recursion Pharmaceuticals RXRX faced a significant setback in May 2025 after announcing the discontinuation of three key drug candidates — REC-994, REC-2282, and REC-3964 — as part of its broader

Universal Health Services, Inc. UHS is set to report second-quarter 2025 results on July 28, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is